Crowley Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-600
Closed -$16.7K 25
2025
Q3
$16.7K Hold
600
0.01% 235
2025
Q2
$14.6K Hold
600
0.01% 232
2025
Q1
$12.5K Hold
600
0.01% 238
2024
Q4
$14.1K Buy
+600
New +$14.8K 0.01% 236

Other funds holding ARKG

Crowley Wealth Management's ARKG Position: Q4 2025 in Review

Crowley Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 600 shares — an estimated $16.7K sold.

Crowley Wealth Management first reported a position in ARKG in Q4 2024 and held it in 4 quarters. The position peaked at $16.7K in Q3 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Crowley Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 600 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $16.7K.
  • Crowley Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's ARK Genomic Revolution ETF position peaked at $16.7K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.